Anthropic is going public. We filed a +2X ETF to trade it.
The company behind Claude has taken its first steps toward an initial public offering. REX Shares has a leveraged ETF on file, built to be ready on day one.
last reviewed September 8, 2026
$ rex describe --fund 2x-long-anthropic
2X Anthropic, in one ticker.
When Anthropic lists, you will not need a margin account, options approval, or a swap desk to take a leveraged position on it. You will need four letters.
$ rex describe --fund
T-REX 2X Long Anthropic Daily Target ETF
Coming Soon
the ticker
Seeks daily investment results, before fees and expenses, of 200% of the daily performance of Anthropic.
01
Leverage without the plumbing
No margin agreement, no options approval, no borrowing. The fund holds the derivatives so you hold a share.
02
Ready on day one
The registration statement is already on file with the SEC. The fund is built to be available when Anthropic stock is, not months after.
03
A defined daily job
200% of Anthropic's move, for one trading day, then it resets. You always know exactly what you own.
$ status anthropic --ipo
Where the offering actually stands.
Every line below is a matter of public record, and the page is updated when something is filed or announced rather than when it is rumored.
$ status anthropic --ipo
registration confidential draft Form S-1, submitted June 1, 2026
public s-1 not yet filed
terms not announced
ticker not assigned
exchange not announced
first trade not scheduled
Anthropic has not announced an IPO date.
A confidential submission is not a public filing. It starts the U.S. Securities and Exchange Commission (SEC) review clock and preserves the option to go public. Source: Anthropic, June 1, 2026, published under Rule 135 of the Securities Act of 1933.
$ odds anthropic-ipo --source kalshi
The market is betting on October 2026.
70%
priced on October 2026 alone
Anthropic has not announced a date, and reporting has pointed loosely at late September or October. Traders are more specific than that. They price only Oct 1, 2026 and earlier at a 3% chance, then jump to 73% by Nov 1, 2026. Almost all of the probability sits in the gap: the single month of October 2026.
It is the only timing signal available anywhere, because nobody involved will give one.
What these odds are actually about. A contract settles Yes when the IPO is confirmed, which means the SEC declares Anthropic's Form S-1 effective, or the offering is priced, or an exchange assigns Anthropic a ticker, whichever comes first. It is not the date the shares start trading. Trading follows confirmation, and it can follow it by weeks.
There is no guarantee these predictions or forecasts will be correct, and are subject to change.
kalshi · probability an IPO is confirmed · as of September 8, 2026
every contract is cumulative, so each row includes all earlier months. beside it is the single month that row implies on its own.
Source: Kalshi series KXIPOANTHROPIC-DATE, kalshi.com. A prediction market is the aggregate opinion of traders, not a forecast by REX Shares and not a statement by Anthropic. The single-month figures are arithmetic on Kalshi's published prices rather than contracts Kalshi lists, and prices move continuously. Reported IPO timing: Financial Times and New York Times, August 2026.
$ why anthropic --highlights
This is the biggest listing on the board.
If Anthropic prices where its own investors expect it to, no company in history will have gone public at a bigger number.
$2T+
What Anthropic backers say they expect the IPO to be valued at.
Six investors, to the Financial Times, Aug 2026
$965B
The last price anyone actually paid, set eight rounds in.
Anthropic, Series H, May 28, 2026
$65B
Annualized revenue run rate, up from about $9 billion eight months earlier.
Anthropic figures reported by Bloomberg and CNBC
14x
Quarterly revenue growth year over year: more than $11.5 billion against $787 million.
Preliminary Q2 figures reported by Bloomberg
If it prices where its backers expect, it is the largest IPO ever.
valuation at pricing · one basis, end to end
Anthropic's bar is an investor expectation, not company guidance, and the offering has not priced. Anthropic executives have not set a valuation target. SpaceX, Aramco and Alibaba are actual valuations at pricing.
Sources: Anthropic Series H announcement, May 28, 2026 (company-stated). Run-rate and quarterly revenue figures are Anthropic figures shared with investors and reported by Bloomberg and CNBC, August 2026. IPO valuation expectation: Financial Times, August 2026. SpaceX valuation at pricing per its Form 424B4, June 2026.
$ why claude
Because the thing it sells is the thing everyone is buying.
Anthropic has one product line: Claude. It sells it mostly to businesses, and the growth above is what those businesses are paying.
$ man anthropic-ipo
FAQs
What is the ticker?
The ticker for the T-REX 2X Long Anthropic Daily Target ETF is coming soon. It seeks daily investment results, before fees and expenses, of 200% of the daily performance of Anthropic, using swap agreements and exchange-traded call options.
It seeks that result for a single trading day and then resets, so it does not seek 200% of Anthropic's return over a week, a month or a year. It cannot begin trading until Anthropic common stock is publicly listed.
Is Anthropic a publicly traded company?
No. Anthropic, PBC is privately held and its stock does not trade on any exchange. It confidentially submitted a draft registration statement on Form S-1 to the U.S. Securities and Exchange Commission (SEC) on June 1, 2026.
When will Anthropic go public?
Anthropic has not announced a date. In its June 1, 2026 statement the company said the confidential submission "gives us the option to go public after the SEC completes its review," and that the proposed offering "will depend on market conditions and other factors."
Prediction market traders on Kalshi price the probability that an IPO is confirmed before Nov 1, 2026 at 73%, and before Oct 1, 2026 at only 3%, as of September 8, 2026. That gap puts roughly 70% on the single month of October 2026. Those contracts settle when the SEC declares the Form S-1 effective, when the offering is priced, or when an exchange assigns a ticker, whichever comes first, so they are not the date the shares begin trading. A prediction market is the aggregate opinion of traders, not a forecast by REX Shares and not a statement by Anthropic.
Does Anthropic have a ticker symbol?
No. Anthropic has not announced a symbol, and one is assigned in connection with a listing. Symbols shown for Anthropic on some finance sites are placeholders or third-party products rather than an assigned ticker.
CLAU is not Anthropic's ticker. It is the ticker for a REX Shares ETF that seeks leveraged exposure to Anthropic, and REX Shares is not affiliated with Anthropic.
Can you buy Anthropic stock today?
Not through an ordinary brokerage account. Anthropic's shares are private, so a retail account cannot hold them, and products marketed under the Anthropic name are issued by third parties rather than by Anthropic. Private-company shares generally change hands only in transactions limited to accredited investors.
What is Anthropic's revenue?
Anthropic's annualized run rate reached about $65 billion at the end of July 2026, a figure shared with investors and reported by Bloomberg and CNBC. Anthropic itself said the run rate crossed $47 billion in May 2026. The company publishes no audited financial statements.
What is Anthropic valued at?
The most recent price paid is $965 billion post-money, set by the Series H round announced on May 28, 2026. Reporting has put an eventual offering higher: six backers told the Financial Times they expect at least $2 trillion, though the same reporting says executives had not set a target.
$ subscribe --anthropic
Stay up to date.
This page is updated when something is actually filed or announced, not when it is rumored. Add your email and REX Shares will send you market and product updates.
"*" indicates required fields
Important Fund Information
The T-REX 2X Long Anthropic Daily Target ETF is a series of ETF Opportunities Trust. Its registration statement is not yet effective and shares are not available for purchase.
An investment in the Fund is not equivalent to investing directly in Anthropic.
BEFORE INVESTING YOU SHOULD CAREFULLY CONSIDER THE FUND’S INVESTMENT OBJECTIVES, RISKS, CHARGES AND EXPENSES. THIS AND OTHER INFORMATION IS IN THE PROSPECTUS, A COPY OF WHICH MAY BE OBTAINED FROM (833) 759-6110 OR AT THE FUND’S PRELIMINARY PROSPECTUS ON EDGAR. PLEASE READ THE PROSPECTUS CAREFULLY BEFORE YOU INVEST.
INFORMATION CONTAINED HEREIN IS SUBJECT TO COMPLETION OR AMENDMENT. A REGISTRATION STATEMENT RELATING TO THESE SECURITIES HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION BUT HAS NOT YET BECOME EFFECTIVE. THESE SECURITIES MAY NOT BE SOLD NOR MAY OFFERS TO BUY BE ACCEPTED PRIOR TO THE TIME THE REGISTRATION STATEMENT BECOMES EFFECTIVE. THIS COMMUNICATION SHALL NOT CONSTITUTE AN OFFER TO BUY OR THE SOLICITATION OF AN OFFER TO BUY NOR SHALL THERE BE ANY SALE OF THESE SECURITIES IN ANY STATE IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL PRIOR TO REGISTRATION OR QUALIFICATION UNDER SECURITIES LAWS OF ANY SUCH STATE.
AN INDICATION OF INTEREST IN RESPONSE TO THIS ADVERTISEMENT WILL INVOLVE NO OBLIGATION OR COMMITMENT OF ANY KIND.
The Fund is not suitable for all investors. The Fund is designed to be utilized only by knowledgeable investors who understand the potential consequences of seeking daily leveraged (2X) investment results, understand the risks associated with the use of leverage and are willing to monitor their portfolios frequently. The Fund is not intended to be used by, and is not appropriate for, investors who do not intend to actively monitor and manage their portfolios. For periods longer than a single day, the Fund will lose money if Anthropic's performance is flat, and it is possible that the Fund will lose money even if Anthropic's performance increases over a period longer than a single day. An investor could lose the full principal value of his/her investment within a single day if the price of Anthropic falls by more than 50% in one trading day.
Fund Risks
Effects of Compounding and Market Volatility Risk. The Fund has a daily leveraged investment objective and the Fund’s performance for periods greater than a trading day will be the result of each day's returns compounded over the period, which is very likely to differ from 200% of Anthropic’s performance, before fees and expenses. Compounding affects all investments, but has a more significant impact on funds that are leveraged and that rebalance daily and becomes more pronounced as volatility and holding periods increase. The effects of compounding will impact each shareholder differently depending on the period of time an investment in the Fund is held and the volatility of Anthropic during the shareholder’s holding period of an investment in the Fund.
Leverage Risk. The Fund obtains investment exposure in excess of its net assets by utilizing leverage and may lose more money in market conditions that are adverse to its investment objective than a fund that does not utilize leverage. An investment in the Fund is exposed to the risk that a decline in the daily performance of Anthropic will be magnified. This means that an investment in the Fund will be reduced by an amount equal to 2% for every 1% daily decline in Anthropic, not including the costs of financing leverage and other operating expenses, which would further reduce its value. The Fund could theoretically lose an amount greater than its net assets in the event of a security decline of more than 50%. This would result in a total loss of a shareholder’s investment in one day even if Anthropic subsequently moves in the opposite direction and eliminates all or a portion of its earlier daily change. A total loss may occur in a single day even if Anthropic does not lose all of its value. Leverage will also have the effect of magnifying any differences in the Fund’s correlation with Anthropic and may increase the volatility of the Fund.
Derivatives Risk. Derivatives are financial instruments that derive value from the underlying reference asset or assets, such as stocks, bonds, or funds (including ETFs), interest rates or indexes. Investing in derivatives may be considered aggressive and may expose the Fund to greater risks, and may result in larger losses or small gains, than investing directly in the reference assets underlying those derivatives, which may prevent the Fund from achieving its investment objective.
FLEX Options Risk. The FLEX Options held by the Fund will be exercisable at the strike price only on their expiration date. Prior to the expiration date, the value of the FLEX Options will be determined based upon market quotations or using other recognized pricing methods. The value of the FLEX Options prior to the expiration date may vary because of related factors other than the value of the reference asset. Factors that may influence the value of the FLEX Options, other than gains or losses in the reference asset, may include interest rate changes, changing supply and demand, decreased liquidity of the FLEX Options, and changing volatility levels of the reference asset.
Indirect Investment Risk. Anthropic is not affiliated with the Trust, the Adviser, or any affiliates thereof and is not involved with this offering in any way, and has no obligation to consider the Fund in taking any corporate actions that might affect the value of the Fund. The Trust, the Fund and any affiliate are not responsible for the performance of Anthropic and make no representation as to the performance of Anthropic. Investing in the Fund is not equivalent to investing in Anthropic. Fund shareholders will not have voting rights or rights to receive dividends or other distributions or any other rights with respect to Anthropic.
Anthropic Investing Risk. Anthropic’s financial performance and valuation may depend on the successful development, commercialization and adoption of its artificial intelligence technologies. The company’s business model may rely on continued demand for advanced AI models, cloud-based AI services and enterprise AI applications. Anthropic may require substantial ongoing investment in research, computing infrastructure and data resources to remain competitive in the AI industry. The company’s growth prospects may also depend on its ability to maintain strategic partnerships, secure access to computing resources and attract and retain highly skilled researchers and engineers. In addition, the long-term commercial applications and revenue models for advanced AI technologies are still evolving, and the market for such technologies may develop differently than currently anticipated. If Anthropic is unable to successfully develop, deploy or monetize its AI technologies, its financial condition, operating results or market valuation could be adversely affected, which could negatively affect the value of the Fund’s investments.
Newly Public Company Risk. Anthropic may have only recently become a publicly traded company and therefore may have a limited operating history as a public company. Newly public companies may experience increased volatility in their stock prices due to factors such as market speculation, evolving investor expectations, limited trading history, changes in analyst coverage, and the transition to public company reporting and governance requirements. In addition, newly public companies may face increased scrutiny from regulators, investors and market participants, and their financial results, business strategies and public disclosures may evolve as they adapt to operating as public companies. These factors may cause the price of Anthropic’s securities to be more volatile than those of more established public companies.
AI Safety and Regulatory Risk. Artificial intelligence technologies are subject to increasing regulatory scrutiny in the United States and internationally. Governments and regulatory bodies are considering and, in some cases, implementing new rules governing the development, deployment and commercialization of advanced AI systems. Such regulations may address areas including model safety testing, transparency, data governance, national security concerns, export controls, intellectual property rights and the potential societal impacts of AI technologies. Compliance with evolving regulatory frameworks may increase operating costs, require modifications to AI models or limit the deployment of certain technologies. Regulatory requirements could also delay the commercialization of AI systems or restrict the availability of certain capabilities in particular markets. In addition, regulatory uncertainty may create operational and strategic challenges for companies operating in the AI industry. Any significant regulatory changes affecting the development or deployment of AI technologies could adversely affect Anthropic’s business, operations or growth prospects, which in turn could negatively affect the value of the Fund’s investments.
Industry Concentration Risk. The Fund will be concentrated in the industry to which Anthropic is assigned (i.e., hold more than 25% of its total assets in investments that provide exposure to the industry to which Anthropic is assigned). A portfolio concentrated in a particular industry may present more risks than a portfolio broadly diversified over several industries. As of the date of this prospectus, Anthropic is assigned to the generative AI and information technology industry.
Non-Diversification Risk. The Fund is classified as “non-diversified” under the Investment Company Act of 1940, as amended. This means it has the ability to invest a relatively high percentage of its assets in the securities of a small number of issuers or in financial instruments with a single counterparty or a few counterparties. This may increase the Fund’s volatility and increase the risk that the Fund’s performance will decline based on the performance of a single issuer or the credit of a single counterparty and make the Fund more susceptible to risks associated with a single economic, political, or regulatory occurrence than a diversified fund.
New Fund Risk. As of the date of this prospectus, the Fund has no operating history and currently has fewer assets than larger funds. Like other new funds, large inflows and outflows may impact the Fund’s market exposure for limited periods of time. This impact may be positive or negative, depending on the direction of market movement during the period affected.
Unlike traditional ETFs, or even other leveraged and/or inverse ETFs, this leveraged single-stock ETF tracks the price of a single stock rather than an index, eliminating the benefits of diversification. Leveraged ETFs pursue daily leveraged investment objectives, which means they are riskier than alternatives which do not use leverage. They seek daily goals and should not be expected to track the underlying stock's performance over periods longer than one day. They are not suitable for all investors and should be utilized only by investors who understand leverage risk and who actively manage their investments.
Anthropic is not affiliated with REX Shares, the Trust, or the Fund's adviser. Investing involves risk, including possible loss of principal. Nothing on this page is a recommendation to buy or sell any security.
Funds distributed by Foreside Fund Services, LLC, member FINRA.
Important Information
Figures on this page are labelled by source. Company-stated means Anthropic published it. Shared with investors means it is Anthropic's own figure, distributed privately and reported by a named outlet, which is not a company announcement and not a filing. Reported means a third-party estimate or press report.
Anthropic is not affiliated with REX Shares, ETF Opportunities Trust, or Tuttle Capital Management. Nothing on this page has been prepared, reviewed, or approved by Anthropic.
Anthropic is a private company. Its securities are not registered for sale to the public and no public trading market for its common stock exists as of the date of this page. A confidential submission of a draft registration statement does not mean an initial public offering will occur. Statements about future events reflect what has been reported by the sources named beside them, are not predictions by REX Shares, and are not assurances that any event will occur.
This page is for informational and educational purposes only. It is not a recommendation to buy or sell any security, it is not investment, legal, or tax advice, and it is not an offer to sell or a solicitation of an offer to buy any security. Investing involves risk, including the possible loss of principal.
REX Shares, LLC, 777 Brickell Avenue, Suite 500, Miami, FL 33131.
